<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED STATEMENT OF EARNINGS AND BALANCE SHEETS OF ALLERGAN, INC. AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH REPORT ON FORM 10Q FOR THE
QUARTER ENDED MARCH 28, 1997
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-28-1997
<EXCHANGE-RATE>                                      1
<CASH>                                         117,600
<SECURITIES>                                         0
<RECEIVABLES>                                  229,900
<ALLOWANCES>                                     7,600
<INVENTORY>                                    134,200
<CURRENT-ASSETS>                               593,100
<PP&E>                                         575,500
<DEPRECIATION>                                 234,900
<TOTAL-ASSETS>                               1,327,100
<CURRENT-LIABILITIES>                          360,800
<BONDS>                                        165,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           700
<OTHER-SE>                                     749,100
<TOTAL-LIABILITY-AND-EQUITY>                 1,327,100
<SALES>                                        256,200
<TOTAL-REVENUES>                               256,200
<CGS>                                           92,600
<TOTAL-COSTS>                                   92,600
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                 1,100
<INTEREST-EXPENSE>                               2,200
<INCOME-PRETAX>                                 25,000
<INCOME-TAX>                                     7,300
<INCOME-CONTINUING>                             17,800
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    17,800
<EPS-PRIMARY>                                      .27
<EPS-DILUTED>                                      .27